Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy

James A Wiseman1,2,3, Glenda M Halliday3,4, Birger Victor Dieriks1,2,3

  • 1Department of Anatomy and Medical Imaging, University of Auckland, Auckland 1023, New Zealand.

PubMed

Insights

Multiple system atrophy (MSA) involves alpha-synuclein (α-Syn) pathology in both neurons and oligodendroglia. Neuronal nuclear invasion by α-Syn drives rapid neurodegeneration in MSA, distinguishing it from Parkinson's disease.

Area of Science:

  • Neuroscience
  • Pathology
  • Cell Biology

Background:

  • Multiple system atrophy (MSA) is a rare, rapidly progressing neurodegenerative disorder often misdiagnosed as Parkinson's disease (PD).
  • MSA is pathologically defined by oligodendroglial cytoplasmic alpha-synuclein (α-Syn) inclusions (GCIs), but exhibits significant non-dopaminergic neuronal loss, unlike PD.
  • The distinct mechanisms of neuronal death and α-Syn toxicity in MSA remain unclear.

Purpose of the Study:

  • To investigate the role of α-Syn pathology in neuronal death in MSA.
  • To compare the characteristics of α-Syn inclusions in neurons and oligodendroglia in MSA.
  • To propose a refined classification for MSA based on distinct pathological features.

Main Methods:

  • Utilized an N-terminus α-Syn antibody to enhance detection of α-Syn pathology.
  • Employed super-resolution microscopy to visualize α-Syn fibril localization and nuclear invasion.
  • Assessed nuclear envelope integrity and Lamin integrity in affected neurons.

Main Results:

  • Identified α-Syn fibrils invading neuronal nuclei from the cytoplasm in MSA, leading to nuclear destruction.
  • Observed rapid nuclear envelope breakdown and loss of Lamin integrity due to α-Syn nuclear pathology.
  • Found evidence of distinct α-Syn proteoforms, with neuronal/nuclear inclusions being more resistant to proteolysis than oligodendroglial GCIs.
  • Demonstrated that neuronal nuclear α-Syn pathology is a rapid and detrimental driver of neurodegeneration in MSA.

Conclusions:

  • Neuronal nuclear invasion by α-Syn is a key mechanism driving rapid neurodegeneration in MSA.
  • MSA exhibits two distinct α-Syn pathologies: neuronal nuclear and oligodendroglial cytoplasmic.
  • Proposed renaming MSA as a neuronal nuclear and oligodendroglial α-synucleinopathy to accurately reflect its distinct pathologies.

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.8K